NEW YORK, Feb. 25, 2016 /PRNewswire/ -- This BCC Research report includes projected trends and sales in the digital pathology and telepathology markets through 2020. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed.
Use this report to:
Analyze forecasted trends and sales in the digital pathology and telepathology markets.
Analyze competitive intelligence and regional trends in digital pathology market.
Receive information about the key market participants, extensive product segments, supporting technologies, and market dynamics of digital pathology and telepathology.
Receive information about the diagnostic, research and development (R&D), and education and training applications related to Telepathology
The global digital pathology market will grow from nearly $3.2 billion in 2015 to nearly $6.5 billion by 2020 with a compound annual growth rate (CAGR) of 15.0% for the period of 2015-2020.
The North American market will grow from $1.3 billion in 2015 to nearly $2.5 billion by 2020 with a CAGR of 13.3%.
The European market is the second largest digital pathology market and will grow from $1.1 billion in 2015 to $1.9 billion by 2020 with a CAGR of 12.2%.
The role of a conventional laboratory is to focus on cost savings, increased laboratory workload and innovative technologies, such as m-health. Digital pathology and telepathology are seen as effective solutions with significant scopes to address the prevailing issues of cost, time and technology. Digital pathology and telepathology offer improved connectivity and reduce healthcare costs. Successful and consistent adoption of digital pathology and telepathology in developed economies is encouraging the developing economies to experiment as well.
The creation of disciplined regulatory environments that protect patient safety and focus on electronic medical records (EMRs), the need for quick diagnoses and the maintenance of cost issues will drive the market. The evolving market, however, presents significant challenges, including significant deployment costs, U.S. Food and
Drug Administration (FDA) approvals, technological complexities, and a lack of skilled staff and conventional pathologists.
The scenario is very different in developing economies, where the concepts of telepathology and digital pathology are so far relevant only to niche and reputed laboratories. There are significant complexities involved in the process of enabling the adoption of novel technologies. Technology providers are having difficulty meeting
varied customer expectations in different regions with respect to the products or services they offer, price and quality. This requires a deeper understanding of the existing infrastructure and process, cost-versus-value expectations, regulatory issues and other driving forces. This report addresses these issues and provides a
comprehensive and objective study to enhance the market presence of participants such as digital pathology technology providers, product manufacturers, service providers, system integrators and other key value chain members.
SCOPE OF THE REPORT
This report includes forecasted trends and sales in the digital pathology and telepathology markets through 2020. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends and competitive scenarios that will form the base data for qualitative analysis and market estimates.
The digital pathology and telepathology market has been analyzed for the four main geographic regions: North America, Europe, Asia and the rest of the world (ROW).
The report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and
information generated from pathology labs and that regarding specific diagnosis, but it will exclude general hospital-based m-health issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.
Read the full report: http://www.reportlinker.com/p02042682-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: email@example.com
Intl: +1 339-368-6001